Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytesDavid L. Downie, Brian Jones, John A. Peters et al.|Neuropharmacology|1994Cited by 50
Characterization of a human 5‐hydroxytryptamine<sub>3</sub> receptor type A (h5‐HT<sub>3</sub>R‐A<sub>S</sub>) subunit stably expressed in HEK 293 cellsAnthony G. Hope, Thomas P. Blackburn, Angus M. Brown et al.|British Journal of Pharmacology|1996Cited by 46
Evidence that the atypical 5‐HT<sub>3</sub> receptor ligand, [<sup>3</sup>H]‐BRL46470, labels additional 5‐HT<sub>3</sub> binding sites compared to [<sup>3</sup>H]‐granisetronLucinda J. Steward, Thomas P. Blackburn, Jian Ge et al.|British Journal of Pharmacology|1995Cited by 30
Characterization of a cloned human 5-hydroxytryptamine-type 3 receptor subunit stably expressed in HEK 293 cellsAnthony G. Hope, Thomas P. Blackburn, J M Balcarek et al.|Behavioural Pharmacology|1995Cited by 0